Translate page

icmlf knowledge centreOctober 2021 - We are delighted to share that the second module on treatment-free remission (TFR), is now available on the iCMLf Knowledge Centre.
This new module features five presentations on this important topic to help clinicians conducting TFR attempts and to manage patient appropriately during these attempts.

Learn more in a short video overview from Professor Tim Hughes, who co-chairs this module together with Dr Katia Pagnano from Brazil.

Now find out more about recent scientific findings and practical considerations on TFR.

icmlf knowledge center bannerSeptember 2021 - Today is World CML Day 9/22 – A perfect day to launch our new iCMLf Knowledge Centre. This interactive, online resource is developed by international CML experts, under the guidance of Professor Giuseppe Saglio. It provides educational content on CML therapy and treatment free remission, practical considerations on the laboratory testing for CML along with CML management strategies in a global setting.

We are happy to share that the first module, CML therapy, is now available on the iCMLf Knowledge Centre.

Refresh your knowledge on CML therapy and learn from leading experts in the field.

You can view a message for World CML Day from the iCMLf by Professor Saglio here. Much has been done, but there is still much to do for global equality in CML management. It is our privilege to work alongside you in our efforts to achieve this.

Collage Bhatia MustjokiAugust 2021 - Join us on World CML Day when we are hosting our next ‘iCMLf Conversation’. This will focus on the biology of CML in relation to treatment-free remission (TFR).

iCMLf Conversation: CML Biology related to TFR

Join our two experts as they discuss key aspects of the biology of CML
specifically related to TFR:

  • Leukemic stem cells and microenvironmental regulation:
    Professor Ravi Bhatia, Director of the University of Alabama Division of Hematology/Oncology and Deputy Director of the O’Neal Comprehensive Cancer Center, University of Alabama
    (Birmingham, USA)
  • Immunology of CML: Professor Satu Mustjoki, Principal Investigator and Group Leader at the Hematology Research Unit Helsinki, Professor of Translational Hematology at the University of Helsinki and Research Professor at the Finnish Cancer Institute (Helsinki, Finland)

Date: September 22nd at 14.30 Central European Summer Time (CEST)

Don’t miss this opportunity and find out about the latest scientific understanding on the biology of CML.

CD5171 FunRun Run Ride Cure RED 01September 2021 - After our successful campaign last year, in October we will again join together to raise funds for the iCMLf. Will you join us on the 2021 Run.Ride.Cure?

Do you want a challenge? Do you need motivation to move after lockdown? Choose your activity and join the CML community to raise much-needed funds for the iCMLf's work to cure CML.

All Funds raised through this challenge will contribute to the iCMLf global research accelerating the development of more effective and safer treatment strategies for people with CML.

Global collaborations lead to ‘Big Data’.

Big data leads to big results.

You can help us!

Choose between three different options to support the Run.Ride.Cure challenge:

Read more and join the Run.Ride.Cure team...

Joerg Hasford We are saddened to share the news of the death of Professor Jörg Hasford last month. Jörg Hasford was a German physician, biometrician, and epidemiologist. For 33 years he was the biometrician of the German CML Study Group and as such a member of the European Investigators on CML. His scientific merits comprise the 5 randomized CML studies of the German CML group 1984 - 2017 and, in cooperation with the European CML investigators, meta-analyses of clinical trials, the EUTOS CML registry and 2 prognostic scores, the EUTOS score and the Euro score carrying his name. Towards the end of his career he got involved in medical ethics. Due to his scientific thoroughness and carefulness he became an expert advisor on clinical trials to the European Commission and was elected President of national European Ethics Committees in Brussels.

We share below the funeral oration from Professor Rüdiger Hehlmann, his close professional colleague.

Abruzzese ChelyshevaJuly 2021 - The next highlight in our series of iCMLf conversations is coming up on August the 5th.
Dr Elisabetta Abruzzese (Rome) and Dr Ekaterina Chelysheva (Moscow) will provide an update on the management of pregnancy during CML treatment.

iCMLf Conversation - CML & Pregnancy

August 5th at 12.00 Central European Time (CET)

Join our two experts as they discuss key aspects of managing pregnancy and CML.

  1. Pregnancy and CML – a balance for the baby:
    Dr Elisabetta Abruzzese, Associate Professor, S Eugenio Hospital, Tor Vergata University, Rome (Italy)

  2. Pregnancy and CML – a balance for the mother:
    Dr Ekaterina Chelysheva, Senior Researcher, National Research Center for Hematology, Moscow (Russian Federation)

There will be an interactive discussion with plenty of room for your questions.